Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Min Gi Kim
CD44-targeted PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Cancer Research
Cancer Research
Oncology
Related publications
PLGA Nanoparticles Codeliver Paclitaxel and Stat3 siRNA to Overcome Cellular Resistance in Lung Cancer Cells
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Octa-Functional PLGA Nanoparticles for Targeted and Efficient siRNA Delivery to Tumors
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
TGFBI Promoter Hypermethylation Correlating With Paclitaxel Chemoresistance in Ovarian Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Leptin Contributes to the Taxol Chemoresistance in Epithelial Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
Retraction Note To: KDM3A Confers Metastasis and Chemoresistance in Epithelial Ovarian Cancer
Journal of Molecular Histology
Medicine
Cell Biology
Histology
Physiology
Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
Clinical Cancer Research
Cancer Research
Oncology
Galectin-1 Overexpression Promotes Progression and Chemoresistance to Cisplatin in Epithelial Ovarian Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Development of Biodegradable PLGA Nanoparticles Surface Engineered With Hyaluronic Acid for Targeted Delivery of Paclitaxel to Triple Negative Breast Cancer Cells
Materials Science and Engineering C
Mechanics of Materials
Materials Science
Condensed Matter Physics
Mechanical Engineering
Paclitaxel-Carboplatin Chemotherapy Induced Hematologic Toxicities Among Epithelial Ovarian Cancer Patients
Universa Medicina